Skip to main content

Table S3.

General characteristics of the studies included.

Study, year (Country) Participants (cases), study design Sample characteristics Exposition (PD) Outcome (ACS) Adjustment factors OR /RR /HR (95% IC)
Starkmammart 2008 [16] (Sweden) 321 (161), CC Both genders. Age: cases 61.0 ± 8.9 (range 33–76); controls 62.0 ± 8.8 (range 35–78 y). Follow-up 3 y. Severity grading of PD (Hugoson & Jordan). Angina (diagnosed as CHD by coronary angiography) Age, smoking OR 5.74 (2.07–15.9) for PD and CAD.
Andriankaja 2006 [17] (USA) 1 337 (537), CC Both genders.
Age: cases 54.6 ± 8.5 (range 35–70); controls: 55.0 ± 0.0, (range 36–70 y). Follow-up 4 y.
CAL, PDe, ACH, NMT MI Age, sex, HT, cholesterol, DM and smoking. OR 2.08 (1.51–2.87) for PD and incidence of non-fatal MI.
Andriankaja 2007 [18] (USA) 1375 (574), CC Both genders. Age 35–69 y.
Follow-up 4 y.
CAL Non-fatal MI (WHO criteria). Age, sex, BMI, physical activity, HT, cholesterol, DM, smoking. OR 1.34 (1.15–1.57) for men and MI. OR 2.08 (1.47–2.94) for women and MI. OR 1.40 (1.06–1.86) for non-smokers and MI. OR 1.49 (1.26–1.77) for smokers and MI.
Rech 2007 [10] (Brazil) 115 (58/57), CC Both genders. Age: cases 59.3 y; controls 70 y. Follow-up 1 y. Gingivitis or Periodontitis. STEMI and non-STE ACS. Age, sex, DM, smoking. OR: 4.5 (1.3–15.6) for PD and MI. OR: 1.8 (0.7–4.7) for PD and ACS.
Geerts 2004 [19] (Belgium) 170 (108), CC Both genders. Age: cases 59.2 ± 11 y; controls 57.7 ± 9 y. Follow-up 4 y. PDe, PPBI, PI, FI, TM. CAD Age, sex, smoking, alcohol, diet, physical activity, HT, DM, and dyslipidemia. OR 6.5 (1.8–23) for CAD and PD.
Geismar 2006 [46] (Denmark) 250 (110), CC Both genders. Age: cases 62.5 ± 11.5 y; controls 62.6 ± 10.5 y. Follow-up 1 y. PDe, CAL, BOP, ABL on radiographs CHD Age, DM, smoking. OR 6.6 (1.69 –25.6) for individuals <60 years, CHD and mean ABL >4. OR 0.8 (0.26 – 2.69) for individuals ≥60 years, CHD and mean ABL >4.
Briggs 2006 [20] (Ireland) 171 (92). CC Men >40 y. Age: cases 56.7 y ± 6.3 y; controls 58.2 ± 6.7 y. Follow-up NR. PI, BOP, PDe. CHD Smoking, academic performance, alcohol, unemployment, body weight, exercise, ability to relax daily, hobby, plaque, and CRP. OR 3.06 (1.02– 9.17) for periodontal status and CHD.
Spahr 2006 [21] (Germany) 789 (263). CC Both genders. Age: cases and controls: 61 ± 7.1 y. Follow-up 3 y. CPITN CHD Age, sex, BMI, smoking, alcohol, DM, HT, dyslipidemia, education, physical activity, statins use. OR 1.67 (1.08–2.58) from an increase in mean CPITN score by 1 and CHD
Cueto 2005 [22] (Spain) 149 (72). CC Both genders. Age: cases 62.5 ± 9.9 y; controls 58.5 ± 10.2 y. Follow-up 2 mo. Grade of periodontitis: percentage of sites with ICP ≥ 3mm. MI Sex, age, smoking, HT, DM, hypercholesterolemia, exercise. OR 3.31 (1.42 – 7.71) for PD and MI.
Anyaipoma 2011 [23] (Peru) 105(35). CC Both genders. Subjects >35 y, non-smokers. Follow-up 6 mo. NT, PDe, adhesion level. Unstable angina, MI HBP, DM, hyperlipidemia, obesity OR 5.899 (1.725 – 20.173) for PD and ACS.
Rutger 2003 [24] (Sweden) 160 (80). CC Both genders. Age: cases 63.4 ± 8.9 y; controls 61.9 ± 9.1 y. Follow-up NR. Marginal ABL. MI Sex, smoking, socio-economic factors OR 7.0 (2–24.3) for periodontitis and MI among non-smokers. OR 14.1 (5.8 – 34.4) for PD and MI regardless of smoking status.
Nonnemacher 2007 [25] (Germany) 90 (50). CC Men. Age: cases 48–80 y, controls 63.6 ±7.3 y. Follow-up 3 y. PDe, CALe, BOP, TL CAD (>30% stenosis) Smoking, BMI. OR 3.2 (1.2–9.0) for PD and CAD.
Buhlin 2005 [26] (Sweden) 193 (143). CC Women. Age: cases 65.9 ± 8.6 (range 43–79 y); controls: 64.5 ± 8.3 (range 45–77 y). Follow-up NR. Remaining teeth, pathological PP (≥ 4 mm). CHD (treated for MI, PTCA, CABG) Age, smoking, DM, BMI, education, place of birth. OR 3.8 (1.68–8.74) for number of PP and CHD
Montebugnoli 2004 [40] (Italy) 113 (63) CC Men. Age: cases 52.3 ± 4.9 (range 40–65 y); controls: 54.5 ± 6.1 y. Follow-up NR. TDI, PTS, CPSS, CRSS. MI <6 months and CHD (≥50% of stenosis) in at least one coronary artery. Age, smoking, hypertension, DM, education, social class, BMI, total cholesterol, triglycerides, LDL cholesterol, HDL cholesterol, and glucose. OR 4.61 (1.0–23.20) for CPSS and CHD.
Coelho 2005 [41] (Brazil) 149 (21) CC Both genders. Age: NR. Follow-up NR. PDe, CALe MI and angina Age, sex, smoking, marital status. OR 4.03 (0.42– 32.43) for PD and MI/angina.
Coelho 2010 [27] (Brazil) 621 (207). CC Both genders. Age: 59 (range 40– 81 y). Follow-up 7 mo. PDe ≥4 mm y
PIC ≥ 3mm, y SS
First MI event Smoking, education level, occupation, DM, HDL cholesterol. OR 1.92 (1.13 – 3.23) for PD and MI.
Górski 2016 [28] (Poland) 289 (134) CC Both genders. Age <70 y. Mean age: cases 54.3 ± 8.1 y; controls 54.9 ± 10.0 y. Follow-up 2 y. Severity (Page & Eke), extent of periodontitis (Arbes Index), TL >10. STEMI and STNEMI (ESC). *Age, sex, smoking, HT, DM, BMI, education, and income. **Age, gender. ***Age, sex, smoking, HT, DM. OR* 2.4 (1.1 –5.2) for extension de PD and MI. OR** 2.0 (1.2–3.5) for severity of PD and MI. OR*** OR 2.1 (1.2–5.9) for TL and MI.
Wojtkowska, 2021 [47] (Poland) 111 (71) CC Both genders. Age: cases 54.22 ± 7.05 y; controls 52 ± 8.43 y. Follow-up 10 mo. Teeth preserved, approximal PI, BOP, PDe, NoPD ≥ 4 mm, %PD ≥ 4 mm, CAL. MI (4th universal definition). Age, sex, medication, smoking, DM, BMI, triglycerides, HDL, HT, FBG OR 1.07 (1.03–1.11) for approximal PI [%]and MI. OR 0.95 (0.9–1.00) for BOP [%]and MI.
Holmlund 2011 [29] (Sweden) 200 (100). CC. Both genders. Age: cases 57.1 ± 5.5 y; controls 57.9 ± 5.2 y. Follow-up NR. PBL, NDP, BOP, NT MI: ECG + CK and troponin T. Age, sex, CRP, HBP, smoking, IL- 6, cholesterol, HDL, DM, TG, BMI, education. OR 4.61 (1.52–13.94) for NDP >4 and MI
Willershausen, 2014 [48] (Germany) 497 (248). CC Both genders. Age: cases 62.3 ± 10.1 (range 51–83); controls 63.5 ± 10.5 y. Follow-up 4 y. Caries frequency (DMFT indices), NT, PPD, BOP, CALe, radiographs Recent MI history, catheterization, reperfusion therapy (PTCA, bypass, or thrombolytics) Sex, age, smoking. OR 0.879 (0.527–1.466) for generalized PD and MI. OR 1.210 (1.148–1.276) for missing teeth and MI. OR 1.541 endodontic origin and MI.
306 (204). CC Both genders. Not DM. Age: cases 64.7 ± 12.9 y; controls 64.2 ± 10.1 y. Follow-up 2 y. CAL, PDe, NMT. MI (ESC) Sex, age, smoking, HT, total cholesterol. OR 2.17 (1.32–3.73) for PDe and MI. OR 1.78 (1.30–2.54) for CAL and MI. OR 1.08 (1.06–1.13) for NMT and MI.
Rydén 2016 [32] (Sweden) 1610 (805). CC Both genders. Age 62.5 ± 8 y. Follow-up 6–10 y. Healthy (≥80% RB), mild- moderate (79%–66% RB), severe PD (<66% RB). MI (3rd universal definition) Smoking, DM, education, marital status. OR 1.28 (1.03–1.60) for PD and MI.
Oe 2009 [31] (Japan) 174 (99). CC Both genders. Age 65.5 ± 10.6 y. Follow-up 3 y. PRS (Renvert et al.). CAD Statin therapy, DM or glucose intolerance, PRS, HT, smoking OR: 2.317 (1.162–4.624) for PRS and CAD.
Khosravi 2013 [64] (Iran) 123 (60). CC. Both genders. Age: cases 54.97 ± 9.68 y; controls: 55.89 ± 11.9 y. Follow-up NR. PDI (Ramfjord), NMT Cardiac enzymes and ECG. Age, DM. OR 8.79 (2.36–32.66) for LOA (< or > 3mm) and MI. OR 5.44 (1.65–17.94) for NMT (< o > 10) and MI. OR 2.32 (0.59–8.42) for PDI score (< or > 4) and MI.
Li 2013 [65] (China) 155 (103). CC. Both genders. Age: cases 68 (range 41–84) y; controls 62 (range 42–78) y. Follow-up: NR. PI, BI, PDe, AL, NMT Blood tests, ECG and US. Sex, age, smoking, BMI, DM, HT, serum lipid. OR 4.89 (1.26–18.94) for AL≥4.00 mm and MI.
Beck 1996 [66] (USA) 1 147 (207) PC Men only. Age: 21–80 y. Follow-up 18 y. Follow-up NR. ABL, worst clinical PDe. Non-fatal MI, angina pectoris, and CHD deaths. Age, BMI, SBP, cholesterol, DM. OR 1.49 (1.04–2.14) for ABL and total CHD
Hujoel 2000 [42] (USA) 8032 (1265). PC Both genders. Age: 25–74 y.
Follow-up 8–10 y.
Russell PI: periodontitis, gingivitis, and no PD. First event of death from CHD or hospitalization due to CHD, or revascularization procedures. Death certificates and medical records Multiple cardiovascular risk factors; demographic, socioeconomic factors, race, poverty rate, education, etc. HR 1.05 (I0.88–1.26) for gingivitis and CHD. HR 1.14 (0.96–1.36) for periodontitis and CHD.
Joshipura 1996 [49] (USA) 44119 (757). RC Men. Age 40–75 y. Follow-up 6 y. Self-reported NT (0, 1–10, 11–16, 17–24, 25+). Incident cases of CHD, including fatal and non-fatal MI and sudden death. Age, BMI, exercise smoking, alcohol, family history of MI, vitamin E RR 1.67 (1.03–2.71) for men with positive PD history, NT ≤ 10 compared with those with NT ≥ 25 and CHD. RR 1.11 (0.74–1.68) for men with negative PD history, NT ≤ 10 compared with those with NT ≥ 25 and CHD.
Howell 2001 [43] (USA) 2653 (797) RC Men. Age 40–84 y. Follow-up 12.3 y. Self-reported TL. Nonfatal MI, nonfatal stroke, CV death, all important CV events (WHO criteria). Age, treatment (aspirin, β-carotene), smoking, alcoholism, HT, BMI, DM, physical activity, paternal history of MI, and history of angina. RR 1.01 (0.82–1.24) for PD and nonfatal MI. RR 1.00 (0.79–1.26) for PD and CV death. RR 1.01 (0.88–1.15) for PD and all-important CV events.
Wu 1999 [50] (USA) 9962 (803). PC Both genders. Age 25–74 y. Follow-up 21 y. Periodontal status: 1) no PD, 2) gingivitis, 3) periodontitis, 4) edentulousness. CVD events ascertained by hospital records for non-fatal events and death certificates for fatal events. Demographic variables and various known CV risk factors. RR 1.03 (0.87–1.21) for gingivitis and CHD; RR 1.14 (0.98–1.34) for periodontitis and CHD; 1.13 (0.98–1.32) for edentulousness and CHD.
Noguchi 2015 [51] (Japan) 3081 (17). RC Men 36–59 y. Follow-up 5 y. Self-administered questionnaire: 1) PS,
2) periodontitis, 3)
TL (<5 and ≥5 teeth)
Participants reports of for MI at annual health examinations Age, BMI, smoking, HT, DM, dyslipidemia, family history of heart disease. OR 2.11 (1.29–3.44) PS and MI. OR 2.26 (0.84–6.02) for periodontitis and MI. OR 1.97 (0.71–5.45) for TL and MI.
Holmlund 2017 [67] (Sweden) 8999 (672). PC. Both sexes. Age 50 ± 13 y. (range 20–85 y. Follow-up 15.8 y. NDP, NT, BOP CVD: MI, stroke, and HF. CVD diagnosis from the Swedish cause of death and the hospital registers. Age, sex, educational level and smoking. RR 1.13 (0.98–1.30) for NDP >4 mm and MI.
Hansen 2016 [68] (Denmark) 100 694 (NR). RC. Both sexes. Age ≥18 y. Follow-up 15 y. Clinical examination and radiographic findings. Periodontitis according to ICD-8 and ICD-10. ICD-10. Age, sex, smoking, comorbidities, medication and socioeconomic status. RR: 1.16 (IC 95% 1.04– 1.30) for periodontitis and MI.
Lee 2017 [44] (Korea) 354850 (8164). PC. Both genders. Age 40–79 y. Follow-up 12 y. Oral examinations. Assessments of MT, gingivitis, periodontitis, and the deposition of calculus (CDC/AAP criteria). Diagnosis was made by physicians during visits using ICD-10 codes. Sex, age, income, insurance, residence, health status, and smoking. OR: 0.88 (0.81–0.97) for PD and MI.
Yu 2015 [33] (USA) 39 863 (642). RC. Women ≥ 45 y. Follow-up 15.7 y. Self-reported PD. CV deaths confirmed by family members, postal authorities, autopsy reports, MR and the National Death Index. MI was assessed by physician review of MR and cardiac enzymes or ECGs. Age, race, BMI, education, smoking, DM, HT, dyslipidemia, family history of MI, physical activity. HR 1.72 (1.25–2.38) for women with incident PD and MI. HR 1.27 (1.04–1.56) for women with prevalent PD and MI.
Dorn 2010 [45] (USA) 884 (154). RC. Both genders. Age 54 ± 8.5 y. Follow-up 2.9 y. Mean CAL. Recurrent overall CVD events (non-fatal, fatal CVD, or cardiac revascularization) Age, sex, education, DM, total cholesterol, statins, antihypertensives, BMI, physical activity, intake of fruits and vegetables, CPK-MB, ejection fraction. HR 1.48 (0.95–2.31) for CAL and overall CVD events among never- smokers. HR 1.00 (0.82–1.23) for CAL and overall CVD events among ever-smokers.
Liljestrand 2015 [35] (Finland) 7629 (253). RC. Both genders. Follow-up 13 y. NMT CHD events: a history of MI, revascularizations, or PTCA. Age, sex, smoking, geographical variable (east/west). HR 2.39 (1.32–4.31) for NMT 5–8 and incident MI. HR 2.1 (1.19–3.71) for NMT 9–31 and incident MI.
Lee 2019 [34] (Korea) 4440970 (31868). RC. Both genders. Mean age 41.5 y. Follow-up 7.59 y. NMT De novo occurrence of MI, HF, ischemic stroke, and all-cause death (ICD-10). Age, sex, BMI, DM, HT, dyslipidemia, COPD, CKD, smoking, alcohol, exercise, income. HR 1.010 (1.007–1.014) for MT and MI.
DeStefano 1993 [69] (USA) 9760 (NR). PC Both sexes. Age 25–74 y. Mean follow-up 14 y. 1) Number of decayed permanent teeth.
2) Periodontal classification: no PD; gingivitis; periodontitis; no teeth.
3) PI.
4) OHI.
CHD: mortality and hospital admission. Age, sex, race, education, poverty rate, marital status, SBP, total cholesterol, DM, BMI, physical activity, alcohol consumption, and smoking. RR 1.72 (1.10–2.68) for periodontitis and death from CHD in men aged 25–49 y. RR 1.25 (1.06–1.48) for periodontitis and death from CHD in men and women aged 25–74 y.
Lee 2015a [70] (Korea) 1025340 (8179). RC. Both genders. Age: 1–80+ y. Follow-up 12 y. Diagnosis of periodontitis according to AAP and ICD-10. Diagnosis made by physician and defined according to the KCD-6. Sociodemographic variables, comorbidities (cerebral infarction, angina pectoris, MI, HT, DM, rheumatoid arthritis, erectile dysfunction, osteoporosis, obesity. OR 0.98 (0.86–1.12) for periodontitis and MI.
Lee 2015b [71] (China) 720343. (10046). RC Both genders. Age 20–65+ y.
Follow-up 11 y.
NR NR Age, sex, socioeconomic status, residence, comorbidities HR 1.23 (1.13–1.35) for PD and MI.
Morrison 1999 [72] (Canada) 9331(416). RC. Both genders. Age 35–84 y. Follow-up 49 y. None, mild gingivitis, severe gingivitis, pockets, loose teeth, edentulous. Fatal CHD. Age, sex, DM, total cholesterol, smoking, HT, and province. RR 2.15 (1.25–3.72) for severe gingivitis and fatal CHD. RR 1.90 (1.17–3.10) for edentulous and fatal CHD.
Bazile 2002 [73] (EUA) 80 (30). CS Both genders. Mean age 54 y. (range 23–83). PI, GI, BOP, PDe, CAL, NMT MI, SA, UA Age, sex. OR 1.23 (0.29–5.23) for CAL and MI. OR 6.10 (1.14–3.26) for CAL UA.
Arbes 1999 [52] (EUA) 5564 (244). CS. Both genders. Age ≥40 y. The percent of periodontal sites per person with CAL ≥ 3 mm. Self-reported history of heart attack (HA) Age, sex, race, poverty, smoking, DM, HT, BMI, cholesterol OR 1.38 (0.75–2.54) for CAL >0–33% and HA. OR 2.28 (1.18–4.39) for CAL >33–67% and HA. OR 3.77 (1.46–9.74) for CAL >67% and HA.
Holmlund 2006 [74] (Sweden) 3352 (NR). CS. Both genders. Age: 20–70 y. ABL, X-ray, BOP, involvement of furcations. Self-reported history of HT and MI. Age, sex, NT, smoking. OR 2.69 (1.12–6.46) for PD and MI in subjects aged 40–60 y.
Parkar 2013 [53] (India). 60 (30). CS Both genders. Age: cases 54.3 ± 11.0 y; controls 53.1 ± 10.5 y. Simplified OHI, CPI, LOA (WHO). STEMI and NSTEMI verified by ECG and serum troponin I level. Age, sex, smoking, alcohol, BMI. OR 0.224 (0.03–1.68) for CPI and MI. OR 0.127 (0.02–1.06) for OHIS and MI. OR 0.79 (I0.009–0.69) for LOA and MI

CAL: clinical attachment loss; PDe: probing depth; alveolar crest height (ACH); PPBI: periodontal pocket bleeding index; PI: plaque index; FI: furcation involvements; TM: tooth mobility; BOP: bleeding on probing; ABL: alveolar bone loss; CPITN: Community Periodontal Index of Treatment Needs; TL: tooth loss; PP: periodontal pockets; TDI: total dental index; PTS: panoramic tomography score; CPSS: clinical periodontal sum score; CRSS: clinical and radiographic sum score; NoPD ≥ 4 mm: the number of bleeding periodontal pockets ≥ 4 mm in depth; %PD ≥ 4 mm: the percentage of bleeding periodontal pockets ≥ 4 mm in depth; NT: number of teeth; PBL: periodontal bone loss; NDP: number of deepened pockets; PPD: probing pocket depths; CALe: clinical attachment level; NMT: number of missing teeth; RB: remaining bone; Periodontal diseases index (PDI); BI: bleeding index; AL: attachment level; PI: periodontal index; OHI: oral hygiene index; PS: periodontal score; GI: gingival index; CPI: community periodontal index; LOA: loss of attachment; PRS: Periodontal risk score; CHD: coronary heart disease; CAD: coronary artery disease; STE: ST segment elevation; ACS: acute coronary syndrome; MI: myocardial infarction; STEMI: ST segment elevation MI; NSTEMI: non-ST segment elevation MI; CV: cardiovascular; CVD: cardiovascular disease; HF: heart failure; ECG: electrocardiogram; PTCA: percutaneous transluminal coronary angioplasty; SA: stable angina; UA: unstable angina; CABG: coronary artery bypass grafting; BMI: body mass index; HT: hypertension; DM: diabetes mellitus; FBG: fasting blood glucose; SBP: systolic blood pressure; US: ultrasonography; WHO: World Health Organization; ESC: European Society of Cardiology; CDC: Centers for Disease Control and Prevention; AAP: American Academy of Periodontology; MR: medical records; KCD-6: Korean Classification of Disease 6TH edition; CC: case-control study; PC: prospective cohort study; RC: retrospective cohort study; CS: cross-sectional study; NR: no reported.